Literature DB >> 17588260

Cholesterol as a bilayer anchor for PEGylation and targeting ligand in folate-receptor-targeted liposomes.

Xiaobin B Zhao1, Natarajan Muthusamy, John C Byrd, Robert J Lee.   

Abstract

Phospholipids have been extensively evaluated as an anchor for both PEGylation and receptor-targeting in liposomal formulations. However, cholesterol, another important component in biomembranes, has not been fully investigated as an alternative anchor. In this study, the potential role of cholesterol for anchoring PEG and folate was investigated. Cholesterol derivatives were synthesized for PEGylation (mPEG-cholesterol) and folate receptor (FR) targeting (folate-PEG-cholesterol) and incorporated into the bilayer of FR-targeted liposomal doxorubicin. The colloidal stability of these cholesterol derivative-containing liposomes was superior to non-PEGylated liposomes, indicating that steric barrier provided by mPEG-cholesterol can efficiently inhibit aggregation of liposomes. FR-targeting activity of these liposomes was demonstrated by in vitro cell-binding studies on FR-overexpressing KB cells. In addition, in vivo circulation of cholesterol-anchored liposomes was prolonged compared to non-PEGylated liposomes. These studies suggest that cholesterol is a viable bilayer anchor for synthesis of PEGylated and FR-targeted liposomes. (c) 2007 Wiley-Liss, Inc. and the American Pharmacists Association.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17588260     DOI: 10.1002/jps.20885

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  20 in total

1.  Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.

Authors:  Kareen Riviere; Zhaohua Huang; Katherine Jerger; Nichole Macaraeg; Francis C Szoka
Journal:  J Drug Target       Date:  2010-03-30       Impact factor: 5.121

2.  The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro.

Authors:  Long Xu; Michael F Wempe; Thomas J Anchordoquy
Journal:  Ther Deliv       Date:  2011-04

3.  Ligands located within a cholesterol domain enhance gene delivery to the target tissue.

Authors:  Long Xu; Jamie Betker; Hao Yin; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2012-03-09       Impact factor: 9.776

Review 4.  Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Authors:  John C Kraft; Jennifer P Freeling; Ziyao Wang; Rodney J Y Ho
Journal:  J Pharm Sci       Date:  2013-11-25       Impact factor: 3.534

5.  Effect of cholesterol nanodomains on the targeting of lipid-based gene delivery in cultured cells.

Authors:  Long Xu; Thomas J Anchordoquy
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

6.  Targeting human clonogenic acute myelogenous leukemia cells via folate conjugated liposomes combined with receptor modulation by all-trans retinoic acid.

Authors:  Hong Li; Yanhui Lu; Longzhu Piao; Jun Wu; Shujun Liu; Guido Marcucci; Manohar Ratnam; Robert J Lee
Journal:  Int J Pharm       Date:  2010-09-29       Impact factor: 5.875

7.  Edible Ginger-derived Nano-lipids Loaded with Doxorubicin as a Novel Drug-delivery Approach for Colon Cancer Therapy.

Authors:  Mingzhen Zhang; Bo Xiao; Huan Wang; Moon Kwon Han; Zhan Zhang; Emilie Viennois; Changlong Xu; Didier Merlin
Journal:  Mol Ther       Date:  2016-08-05       Impact factor: 11.454

8.  Polymer-coated echogenic lipid nanoparticles with dual release triggers.

Authors:  Rahul Nahire; Manas K Haldar; Shirshendu Paul; Anaas Mergoum; Avinash H Ambre; Kalpana S Katti; Kara N Gange; D K Srivastava; Kausik Sarkar; Sanku Mallik
Journal:  Biomacromolecules       Date:  2013-02-20       Impact factor: 6.988

9.  Preparation, characterization and pharmacokinetics of folate receptor-targeted liposomes for docetaxel delivery.

Authors:  Guangxi Zhai; Jun Wu; Guangya Xiang; Wenxue Mao; Bo Yu; Hong Li; Longzhu Piao; L James Lee; Robert J Lee
Journal:  J Nanosci Nanotechnol       Date:  2009-03

10.  The effects of lipoplex formulation variables on the protein corona and comparisons with in vitro transfection efficiency.

Authors:  Jamie L Betker; Joe Gomez; Thomas J Anchordoquy
Journal:  J Control Release       Date:  2013-08-03       Impact factor: 9.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.